Emerging Biomedical Technologies for Personalized Medicine from Bench to Bedside

Journal of Biomedical Systems & Emerging Technologies

ISSN: 2952-8526

Open Access

Opinion - (2023) Volume 10, Issue 1

Emerging Biomedical Technologies for Personalized Medicine from Bench to Bedside

Rajeev Shukla*
*Correspondence: Rajeev Shukla, Department of Biomedical Technology, University of Ioannina, Ioannina, Greece, Email:
Department of Biomedical Technology, University of Ioannina, Ioannina, Greece

Received: 28-Dec-2022, Manuscript No. bset-23-94647; Editor assigned: 02-Jan-2023, Pre QC No. P-94647; Reviewed: 14-Jan-2023, QC No. Q-94647; Revised: 21-Jan-2023, Manuscript No. R-94647; Published: 28-Jan-2023 , DOI: 10.37421/2952-8526.2023.10.154
Citation: Shukla, Rajeev. “Emerging Biomedical Technologies for Personalized Medicine from Bench to Bedside.” J Biomed Syst Emerg Technol 10 (2023): 154.
Copyright: © 2023 Shukla R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Personalized medicine, also known as precision medicine, is an evolving approach to healthcare that seeks to tailor medical treatments to an individual's unique characteristics, such as their genetic makeup, lifestyle, and environmental factors. This approach has gained significant attention in recent years, and several emerging biomedical technologies are being developed to advance personalized medicine from the bench to the bedside [1]. Here are some notable examples:

Genomic sequencing: Genomic sequencing is a key technology that enables personalized medicine by allowing for the analysis of an individual's genetic information. Next-generation sequencing (NGS) technologies have revolutionized genomic sequencing by enabling faster, more accurate and cost-effective DNA sequencing. These technologies have been applied in various clinical settings, including cancer genomics, rare genetic disease diagnosis, and pharmacogenomics, to guide personalized treatment decisions based on an individual's genetic profile.

Liquid Biopsy: Liquid biopsy is a non-invasive diagnostic technique that involves the analysis of genetic mutations, alterations, and other biomarkers in a patient's blood or other bodily fluids. Liquid biopsy has emerged as a promising technology for early cancer detection, monitoring treatment response, and detecting minimal residual disease. It has the potential to replace invasive tissue biopsies and provide real-time information on a patient's disease status, which can guide personalized treatment decisions.

CRISPR-Cas9 gene editing: CRISPR-Cas9 is a revolutionary gene editing technology that allows for precise manipulation of the DNA sequence. It has the potential to correct genetic mutations that cause diseases and holds promise for personalized medicine. CRISPR-Cas9 has been used in preclinical and clinical studies to treat genetic diseases, including sickle cell anemia and certain types of inherited blindness. However, there are still ethical and safety considerations that need to be addressed before widespread clinical applications.

Microbiome analysis: The human microbiome, which consists of trillions of microorganisms that live in and on our bodies, has been recognized as a critical factor in health and disease. Emerging technologies, such as metagenomics and metatranscriptomics, allow for the comprehensive analysis of the microbiome, providing insights into the complex interactions between microbial communities and their host. Microbiome analysis has the potential to guide personalized interventions, such as targeted probiotics or fecal microbiota transplantation, for various conditions, including gastrointestinal disorders, metabolic diseases, and mental health disorders [2].

Wearable devices and digital health: Wearable devices, such as fitness trackers, smartwatches, and continuous glucose monitors, have gained widespread popularity in recent years and are increasingly being used in personalized medicine. These devices can collect real-time data on an individual's physiological parameters, behaviors, and environmental exposures, which can be used to generate personalized health insights and recommendations. In combination with digital health technologies, such as electronic health records (EHRs), telemedicine, and artificial intelligence (AI)- powered analytics, wearable devices have the potential to transform healthcare delivery and enable personalized interventions for better health outcomes.

3D printing: 3D printing, also known as additive manufacturing, has emerged as a promising technology for personalized medicine, particularly in the field of medical implants and prosthetics. 3D printing allows for the fabrication of complex and customized medical devices, such as implants, prosthetics, and surgical guides, based on an individual's anatomical data. This enables precise fitting, improved functionality, and reduced complications. 3D printing has been applied in various medical specialties, including orthopedics, cardiology, and dentistry, and has the potential to revolutionize patient care by providing tailored solutions for individual patients [3,4].


Emerging biomedical technologies are revolutionizing the field of personalized medicine, taking it from the bench to the bedside. These technologies are enabling healthcare providers to tailor medical treatments and interventions to the unique characteristics of each individual patient, resulting in more effective and precise healthcare outcomes. From genomics and proteomics to digital health and artificial intelligence, the rapid advancements in biomedical technologies are paving the way for a new era of personalized medicine.

With the ability to analyze an individual's genetic makeup, molecular profile, and health data in real-time, healthcare providers can make informed decisions on diagnosis, prognosis, and treatment options. This has the potential to greatly improve patient outcomes and reduce healthcare costs by minimizing trial and error in treatment plans, avoiding unnecessary interventions, and optimizing medication regimens [5].

Furthermore, these technologies are empowering patients to take control of their own health, as they gain access to personalized health information, tools, and interventions. Patients are becoming more engaged in their healthcare decisions, making informed choices based on their unique health profiles and preferences. This shift towards patient-centric care is resulting in better patient satisfaction, increased compliance with treatment plans, and improved overall health outcomes.

However, as with any rapidly evolving field, there are challenges and ethical considerations associated with the use of emerging biomedical technologies in personalized medicine. Issues such as data privacy, equity in access to these technologies, and ethical implications of genetic testing and gene editing require careful consideration and regulation to ensure responsible and equitable implementation.


Emerging biomedical technologies are transforming the landscape of personalized medicine, offering unprecedented opportunities to improve patient care and outcomes. With continued research, development, and responsible implementation, these technologies have the potential to revolutionize the way healthcare is delivered, making it more precise, efficient, and patient-centered. As we continue to unlock the potential of personalized medicine, we can expect to see further advancements in the field, leading to a new era of healthcare that is truly tailored to the individual needs of each patient.


  1. Lattanzi, Wanda, Cristian Ripoli, Viviana Greco, and Marta Barba, et al. "Basic and preclinical research for personalized medicine." J Pers Med 11 (2021): 354.
  2. Google Scholar, Crossref, Indexed at

  3. Constantinou, Kyriacos P., Ioannis P. Constantinou, Constantinos S. Pattichis, and Marios S. Pattichis. "Medical image analysis using AM-FM models and methods." IEEE Rev Biomed Eng 14 (2020): 270-289.
  4. Google Scholar, Crossref, Indexed at

  5. Alsaigh, Tom, Belinda A. Di Bartolo, Jocelyne Mulangala, and Gemma A. Figtree, et al. "Bench-to-bedside in vascular medicine: optimizing the translational pipeline for patients with peripheral artery disease. Circ Res 128 12 (2021): 1927-1943.
  6. Google Scholar, Crossref, Indexed at

  7. Armstrong, James PK, and Molly M. Stevens. "Emerging technologies for tissue engineering: from gene editing to personalized medicine." Tissue Eng Part A 25 9-10 (2019): 688-692.
  8. Google Scholar, Crossref, Indexed at

  9. Joda, Tim, Michael M. Bornstein, Ronald E. Jung, Marco Ferrari, Tuomas Waltimo, and Nicola U. Zitzmann. "Recent trends and future direction of dental research in the digital era." Int J Environ Res Public Health17 (2020): 1987.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 47

Journal of Biomedical Systems & Emerging Technologies received 47 citations as per Google Scholar report

Journal of Biomedical Systems & Emerging Technologies peer review process verified at publons

Indexed In

arrow_upward arrow_upward